CAMLINFINE — Camlin Fine Sciences Balance Sheet
0.000.00%
- IN₹15.47bn
- IN₹20.62bn
- IN₹17.23bn
Annual balance sheet for Camlin Fine Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,288 | 952 | 812 | 1,433 | 1,118 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,537 | 3,937 | 3,656 | 4,221 | 5,251 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,935 | 10,878 | 10,007 | 11,834 | 12,365 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,403 | 8,344 | 8,023 | 6,536 | 6,579 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 18,001 | 20,601 | 19,517 | 20,238 | 23,239 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,953 | 7,930 | 7,323 | 8,462 | 9,744 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 10,521 | 12,407 | 10,870 | 11,221 | 12,830 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 7,479 | 8,194 | 8,648 | 9,017 | 10,409 |
| Total Liabilities & Shareholders' Equity | 18,001 | 20,601 | 19,517 | 20,238 | 23,239 |
| Total Common Shares Outstanding |